Mode
Text Size
Log in / Sign up

Measles incidence increased in Galmudug State, Somalia, from 2023 to 2024.

Measles incidence increased in Galmudug State, Somalia, from 2023 to 2024.
Photo by CDC / Unsplash
Key Takeaway
Consider the increased measles incidence in Galmudug State as a signal for enhanced immunization and surveillance efforts.

This retrospective cross-sectional study analyzed 1,705 suspected measles cases in Galmudug State, Somalia, from April 2023 to December 2024. Of these, 104 were laboratory confirmed. The primary exposure was the temporal trend over this period.

The incidence rate increased from 4.9 per 10,000 population in 2023 to 8.1 per 10,000 in 2024. Among suspected cases, 6.0% were laboratory confirmed (104 confirmed out of 1,705 suspected). The highest burden was among children aged 5–9 years (30%), followed by those aged 0–4 years (25.9%). Dusamareb District accounted for 95.8% of reported cases. No significant gender difference was observed (p = 0.639).

The IgM-positive test rate was significantly higher in children aged 10–14 years and 0–4 years compared to other age groups (11.3% higher for 10–14 years; 7.7% higher for 0–4 years; p < 0.05). Safety and tolerability data were not reported.

Key limitations include the retrospective, cross-sectional design, which cannot establish causality, and the focus on a single region. The practice relevance suggests strengthening routine immunization, ensuring equitable vaccine access, and enhancing surveillance to achieve measles elimination targets.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundMeasles remains a significant public health concern in Somalia, with recurrent outbreaks despite the availability of vaccines. This retrospective study aimed to examine the trends of measles outbreaks in Galmudug State, Somalia, between April 2023 and December 2024.MethodsA retrospective cross-sectional study was conducted using surveillance data from the Galmudug State Public Health Laboratory. All suspected and laboratory-confirmed measles cases reported between April 2023, and December 2024 were included. Data was analyzed using Microsoft Excel and SPSS version 26, focusing on demographic characteristics, temporal distribution, and IgM confirmation rates. Descriptive statistics, the chi-square (χ2) test and logistic regression analyses were performed, with statistical significance set at p < 0.05.ResultsA total of 1,705 suspected measles cases were reported during the study period, of which 104 (6.0%) were laboratory confirmed. The incidence rate increased from 4.9 per 10,000 population in 2023 to 8.1 per 10,000 in 2024. The highest burden occurred among children aged 5–9 years (30%), followed by those aged 0–4 years (25.9%). Dusamareb District accounted for 95.8% of reported cases. No significant gender difference was observed (p = 0.639).Logistic regression analysis also revealed that the rate of IgM-positive test in children aged 10–14 years and 0–4 years was significantly higher (p < 0.05) by 11.3 and 7.7%, respectively, compared to other age groups.ConclusionThe resurgence of measles in Galmudug indicates persistent immunity gaps and inadequate vaccination coverage, particularly among young children. Strengthening routine immunization, ensuring equitable access to vaccines, and enhancing surveillance and outbreak response mechanisms are critical to achieving measles elimination targets in the region.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.